Synthesis and insulinomimetic activities of novel mono- and tetranuclear oxovanadium(IV) complexes with 3-hydroxypyridine-2-carboxylic acid

Journal of Inorganic Biochemistry

Volumn 98, Issue 1, 2004, Pages 105-112

  Nakai, Misaki ^a   Obata, Makoto ^a   Sekiguchi, Fumi ^a   Kato, Masako ^a   Shiro, Motoo ^b   Ichimura, Akio ^c   Kinoshita, Isamu ^c   Mikuriya, Masahiro ^d   Inohara, Toshifumi ^e   Kawabe, Kenji ^e   Sakurai, Hiromu ^e   Orvig, Chris ^f   Yano, Shigenobu ^a  

^a NARA WOMEN'S UNIVERSITY   (Japan)

^b RIGAKU CORPORATION   (Japan)

^c Osaka Prefecture University   (Japan)

^d KWANSEI GAKUIN UNIVERSITY   (Japan)

^e KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cyclic tetranuclear complex; Insulinomimetic activity; Oxovanadium

Indexed keywords

3 HYDROXYPYRIDINE 2 CARBOXYLIC ACID; BIS(PYRIDINE 2 CARBOXYLATO)OXOVANADIUM; CARBOXYLIC ACID DERIVATIVE; FATTY ACID; UNCLASSIFIED DRUG; VANADIUM DERIVATIVE;

ABSORPTION SPECTROPHOTOMETRY; ADIPOCYTE; ANIMAL CELL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CYCLIC POTENTIOMETRY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRON SPIN RESONANCE; INFRARED SPECTROMETRY; INSULINOMIMETIC ACTIVITY; MAGNETISM; MASS SPECTROMETRY; MOLECULAR INTERACTION; NONHUMAN; RAT; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 10744230190     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2003.09.005     Document Type: Article

References (21)

1. Dubyak G.R., Kleinzeller A. J. Biol. Chem. 255:1980;5306-5312.
2. Thompson K.H., McNeill J.H., Orvig C. Chem. Rev. 99:1999;2561-2571.
3. Tracey A.S., Crans D.C. Vanadium compounds; chemistry, biochemistry, and therapeutic applications. ACS Symposium Series. 711:1998;American Chemical Society, Washington, DC.
4. Sakurai H. Chem. Record. 2:2002;237-248.
5. Heyliger C.T., Tahiliani A.G., McNeill J.H. Science. 227:1985;1474-1477.
6. Sakurai H., Tsuchiya K., Nukasuka M., Sofe M., Kawada J. J. Endocrinol. 126:1990;451-459.
7. Meyerovitch J., Faefel Z., Sack J., Shechter Y. J. Biol. Chem. 262:1987;6658-6662.
8. Sakurai H., Fujii K., Watanabe H., Tamura H. Biochem. Biophys. Res. Commun. 214:1995;1095-1101.
9. Fujimoto S., Fujii K., Yasui H., Matsushita R., Takada J., Sakurai H. J. Clin. Biochem. Nutr. 23:1997;113-129.
10. Takino T., Yasui H., Yoshitake A., Hamajima Y., Matsushita R., Tanaka J., Sakurai H. J. Biol. Inorg. Chem. 6:2001;133-142.
11. Kiss E., Petrohan K., Sanna D., Garribba E., Micera G., Kiss T. Polyhedron. 19:2000;55-61.
12. Yano S., Nakai M., Sekiguchi F., Obata M., Kato M., Shiro M., Kinoshita I., Mikuriya M., Sakurai H., Orvig C. Chem. Lett. 9:2002;916-917.
13. Kiss E., Bényei A., Kiss T. Polyhedron. 22:2003;27-33.
14. SIR97 program: Altomare A., Burla M.C., Camalli M., Cascarano G.L., Giacovazzo C., Guagliardi A., Moliterni A.G.G., Polidori G., Spagna R. J. Appl. Cryst. 32:1999;115-119.
15. DIRDIF94 program: Beurskens P.T., Admiraal G., Beurskens G., Bosman W.P., deGelder R., Israel R., Smits J.M.M. "The DIRDIF-94 program system", Technical Report of the Crystallography Laboratory. 1994;University of Nijmegen, The Netherlands.
16. Jørgensen C.K. Acta Chem. Scand. 11:1957;73-85.
17. Ballhausen C.J., Gray H.B. Inorg. Chem. 1:1962;111-122.
18. Caulder D.L., Raymond K.N. Acc. Chem. Res. 32:1999;975-982.
19. Leininger S., Olenyuk B., Stang P.J. Chem. Rev. 100:2000;853-908.
20. Ooi S., Nishizawa M., Matsumoto K., Kuroya H., Saito K. Bull. Chem. Soc. Jpn. 52:1979;452-457.
21. Mahroof-Tahir M., Keramidas A.D., Goldfarb R.B., Anderson O.P., Miller M., Crans D.C. Inorg. Chem. 36:1997;1657-1668.